Screener
Mirum Pharmaceuticals, Inc. MIRM EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s EBITDA margin?
- Mirum Pharmaceuticals, Inc. (MIRM) reported EBITDA margin of -130.7% in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s EBITDA margin changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s EBITDA margin decreased by 1607.5% year-over-year, from -7.7% to -130.7%.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s EBITDA margin?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s EBITDA margin has grown at a -85.5% compound annual growth rate (CAGR), from -903% to 0.4%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Mirum Pharmaceuticals, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude